Radiologie (Heidelberg, Germany)HumansMaleAndrostenesGlutamate Carboxypeptidase IINuclear Medicine
[Options in nuclear medicine for advanced prostate cancer in practice].
Sophie Carina Siegmund, Philipp M Kazmierczak, Adrien Holzgreve, Christian G Stief, Jozefina Casuscelli, Marcus Unterrainer, Lena M Unterrainer
Published: 202510.1007/s00117-025-01527-w
Abstract
Over the last few years diagnostic and therapeutic advances have contributed to the significant relevance of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and PSMA radioligand therapy in patients…
Preview only. Read the full abstract at the source